Alixia
Alixia, formerly known as Guided Clarity, is a healthcare company based in San Francisco, specializing in therapeutics for cancer and age-related diseases.
Founders
Alixia was founded by Olof Mollstedt and Helen Chen, Ph.D. Olof Mollstedt holds B.S. and M.S. degrees in Engineering Physics from Chalmers University of Technology in Sweden and École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland. Helen Chen, Ph.D., has over 15 years of experience in the biotech industry. She was previously the Chief Operations Officer at Ambryx Biotechnology. Helen Chen earned her B.S. in molecular biochemistry and biophysics from Yale University and her Ph.D. in biomedical sciences from UCSD, School of Medicine.
History
Alixia, formerly known as Guided Clarity, is based in San Francisco, CA, USA. The company operates within the Healthcare industry, specifically in Therapeutics. It participated in the Y-Combinator W22 batch. Alixia's mission is to develop innovative therapeutic solutions targeting age-related diseases, cancer, and immune dysregulation.
Services
Alixia focuses on developing therapeutic compounds that disrupt metabolic and inflammatory triggers within cancer and quasi-cancerous cells. The company aims to address multiple age-related diseases through an integrated approach that involves biology, biophysics, computational chemistry, and clinical input.
Research and Development
Alixia's therapeutic portfolio includes programs at various stages of preclinical development. These programs target critical areas such as cancer, aging, inflammation, and immune dysregulation. The lead compounds are designed to disrupt the metabolic and inflammatory processes that contribute to disease progression in the microenvironment of targeted cells.
Team Size and Location
Alixia operates with a small but specialized team of 2 members, based in San Francisco, CA, USA. The company's focus spans across the United States and America/Canada regions.